NanoViricides Inc (NNVC)

US · Healthcare · Biotechnology

$1.32+2.33%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-2.2M

EPS

$-0.10

EPS estimate

$-0.11

EPS came in at -0.10 against a street estimate of -0.11 — a beat of 9.1%.

Market cap

$32.9M

Forward P/E

0.0

P/B

4.06

Book value

$0.38

EPS (TTM)

$-0.41

52-week high

$2.03

52-week low

$0.85

50-day MA

$1.32

200-day MA

$1.29

Beta

1.83

Analysts rate NanoViricides Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $6.00.

Insiders

2.49%

Institutions

9.34%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NanoViricides Inc — free to start.

Data updated 2026-11-07.